Pancreatic cancer (PC) is one of the most common malignancies. Surgical resection is a
potential curative approach for PC, but most patients are unsuitable for operations when at …

Pancreatic cancer is one of the most lethal human malignancies, in part because it is often
diagnosed at late stages when surgery and systemic therapies are either unfeasible or …

This systematic review and meta-analysis evaluated the prognostic role of cell-free DNA
(cfDNA) in pancreatic ductal adenocarcinoma (PDAC). Eligible studies reported differences …

Aims We previously showed that the nab-paclitaxel plus S-1 (NPS) regimen had promising
effects against metastatic pancreatic ducal adenocarcinoma (mPDAC), whose efficacy …

Proteins localized on the surface or within the lumen of tumor‐derived extracellular vesicles
(EVs) play distinct roles in cancer progression. However, quantifying both populations of …

Background: The impact of KRAS mutation testing on pancreatic ductal adenocarcinoma
(PDAC) samples by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for …

Background An early diagnosis of pancreatic cancer (PC) is extremely difficult because of
the lack of sensitive liquid biopsy methods and effective biomarkers. We attempted to …

Abstract Background Circulating tumor DNA (ctDNA) has emerged as a potential diagnostic
and prognostic biomarker in various tumors. However, the role of tumor suppressor genes …

Background Pancreatic adenocarcinoma (PDAC) is associated with a 5‐year survival rate of
less than 6%, and current treatments have limited efficacy. The diagnosis of PDAC is mainly …

Evidence comparing ultrasound endoscopy-guided fine-needle biopsy (EUS-FNB) with EUS-
guided fine-needle aspiration (EUS-FNA) in deep-seated lymphoma tissue sampling is …